Transplantation

Oral Vaccine Tested That Prevents Corneal-Transplant Rejection

Published in Vaccine Weekly, October 6th, 1997

Ophthalmologists at the University of Texas Southwestern Medical Center at Dallas, Texas, have developed an oral vaccine that may prevent rejection of corneal transplants, the most common type of tissue transplant.

About 40,000 corneal transplants are performed in the United States each year with a success rate approaching 90 percent; however, UT Southwestern ophthalmologists are conducting research to help the 10 percent who continually reject corneal transplants. The ophthalmologists are perfecting a novel oral vaccine that slowly trains the recipient's immune system to accept donated corneas.

"Even in the face of powerful immunosuppressive...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1997-10-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry